A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury.
Kidney Int Rep
; 7(12): 2714-2717, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36120390
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article